Safety and anterior chamber structure of evolution implantable Collamer lens implantation with short white-to-white corneal diameters

Xun Chen, Fang Chen, Xuanqi Wang, Yilin Xu, Mingrui Cheng, Tian Han, Xiaoying Wang, Xingtao ZhouFrontiers in Medicine 2022 · DOI

Abstract

EVO-ICL implantation in patients with short white-to-white (WTW) corneal diameters (≤ 10.6 mm) was determined to be a safe, effective, and predictable method for correcting myopia. The changes in the anterior chamber structure were still within normal limits after the surgery, the intraocular pressure (IOP) remained stable, and the ideal vault was achieved after the surgery.

Introduction

For patients with high myopia, the Evolution Implantable Collamer Lens (EVO-ICL) offers a robust alternative to laser-based refractive surgeries. However, the success of ICL implantation depends heavily on the lens "fit" within the eye's internal dimensions. Traditionally, surgeons use the white-to-white (WTW) distance—the horizontal diameter of the cornea—as a proxy for the internal space.

A significant clinical challenge arises because official sizing calculators often do not recommend ICL implantation for patients with a WTW of less than 10.65 mm. This limitation is particularly relevant for East Asian populations, where shorter WTW diameters are more prevalent. Concerns regarding potential crowding of the anterior chamber, elevated intraocular pressure (IOP), or natural lens damage have historically deterred surgeons from treating these patients. This study aims to provide clinical evidence for the safety and efficacy of EVO-ICL in eyes with short WTW diameters.

Methods

Researchers at Fudan University Eye Ear Nose and Throat Hospital conducted a prospective study comparing two cohorts:

  • Experimental Group: 34 eyes with a WTW ≤ 10.6 mm.
  • Control Group: 59 eyes with a WTW > 10.6 mm.

All participants received the 12.1 mm EVO-ICL, the smallest available size. Advanced imaging techniques, including Pentacam HR and Ultrasound Biomicroscopy (UBM), were employed to measure the "vault" (the clearance between the ICL and the natural lens) and the sulcus-to-sulcus (STS) diameter—a direct measurement of the internal space where the lens haptics reside.

Results

Visual Outcomes and Safety

The study demonstrated excellent safety and efficacy profiles for both groups. The safety index (postoperative/preoperative visual acuity) was 1.17 for the experimental group and 1.12 for the control group. Notably, no eyes in either group lost lines of corrected distance visual acuity (CDVA).

Figure 1: Changes in CDVA (Snellen lines) after EVO-ICL implantation between experimental and control groups.

In terms of efficacy, the experimental group showed a slightly higher effectiveness index (1.16 vs. 1.07). Predictability was also high, with 100% of eyes in the experimental group falling within ±1.00 D of the target refractive correction.

Figure 2: Cumulative percentage of eyes achieving specific postoperative uncorrected distance visual acuity (UDVA) levels.

Vault and Internal Structure

The "vault" is a critical metric for ICL safety; a vault that is too high can lead to glaucoma, while one that is too low can cause cataracts. Both groups achieved an "ideal vault," with averages of 395.76 ± 155.32 μm for the experimental group and 389.49 ± 135.01 μm for the control group. This indicates that the 12.1 mm lens fits appropriately even when the external corneal diameter is small.

Furthermore, while the anterior chamber volume decreased postoperatively as expected, the changes remained within safe physiological limits. Intraocular pressure remained stable across all patients, and no adverse events like angle closure were reported.

Discussion

A key finding of this research is that WTW is merely a proxy, not an absolute rule for internal eye dimensions. The study found no statistical difference in the internal STS diameter between the two groups, despite their significant differences in external WTW measurements. This suggests that eyes with small external diameters may still possess adequate internal space for ICL implantation.

Limitations

The study is limited by a relatively short follow-up period of one month. Long-term monitoring is necessary to observe how the aging process and natural lens thickening might affect these smaller anterior chambers. Additionally, the small sample size (n=34 for the experimental group) and a high proportion of female participants may limit the generalizability of the findings.

Conclusion

EVO-ICL implantation is a safe and effective option for patients with short WTW corneal diameters (≤ 10.6 mm). Surgeons should consider relying more on direct internal measurements, such as UBM-measured STS and anterior chamber structure, rather than solely on WTW when determining candidacy for ICL surgery in patients with small eyes.

Summary updated

Abstract

EVO-ICL implantation in patients with short WTW corneal diameters (≤ 10.6 mm) was determined to be a safe, effective, and predictable method for correcting myopia. The changes in the anterior chamber structure were still within normal limits after the surgery, the IOP remained stable, and the ideal vault was achieved after the surgery.
BibTeX
@inproceedings{chen2022safety,
  author = {Xun Chen and Fang Chen and Xuanqi Wang and Yilin Xu and Mingrui Cheng and Tian Han and Xiaoying Wang and Xingtao Zhou and Xiaoying Wang and Xingtao Zhou},
  title = {{Safety and anterior chamber structure of evolution implantable Collamer lens implantation with short white-to-white corneal diameters}},
  booktitle = {Frontiers in Medicine},
  year = {2022},
  doi = {10.3389/fmed.2022.928245},
}

Loading related content...

Figure